CTOs on the Move


 
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nymox.com
  • Heights Plaza 777 Terrace Avenue
    Hasbrouck Heights, NJ USA 07604
  • Phone: 800.936.9669

Executives

Name Title Contact Details

Funding

Nymox raised $16.3M on 04/12/2018

Similar Companies

Christ Community Health Services Augusta

Christ Community Health Services Augusta is a non-profit organization that provides affordable, quality primary health and dental care for the uninsured, the under insured and the under served of Augusta, Georgia.

Health Scholars

Health Scholars is transforming clinical education and training. Our mission is to advance healthcare education through virtualization, making experience-based training scalable, accessible and affordable to both Healthcare and Public Safety providers.

PlasmaCare

PlasmaCare is a Hampton, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaCann

PharmaCann is Improving lives, committed to truth and transparency, bringing the cannabis industry to scale.

Ascension

Ascension is one of the largest private healthcare systems in the United States, ranking second in the United States by number of hospitals as of 2019.